Pulmonary Hypertension and Heart Failure A Dangerous Liaison

被引:12
|
作者
Guazzi, Marco [1 ]
机构
[1] IRCCS, Policlin San Donato, Heart Failure Unit, Piazza E Malan 2, I-20097 Milan, Italy
关键词
Pulmonary hypertension; Heart failure; Mean pulmonary artery pressure; Left atrial pressure; Right heart dysfunction; Pulmonary vascular resistance; PRESERVED EJECTION FRACTION; INHALED NITRIC-OXIDE; RIGHT-VENTRICULAR-FUNCTION; CAPILLARY WEDGE PRESSURE; IMPROVES EXERCISE HEMODYNAMICS; ARTERIAL SYSTOLIC PRESSURE; DOUBLE-BLIND; PHOSPHODIESTERASE-5; INHIBITION; VENTILATORY EFFICIENCY; ENDOTHELIN ANTAGONIST;
D O I
10.1016/j.hfc.2018.02.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension (PH) is a common hemodynamic evolution of heart failure (HF) with preserved or reduced ejection fraction, responsible for congestion, symptoms worsening, exercise limitation, and negative outcome. In HF of any origin, PH develops in response to a passive backward pressure transmission as a result of increased left atrial pressure. Sustained pressure injury and chronic venous congestion can trigger pulmonary vasoconstriction and vascular remodeling, leading to irreversible pulmonary vascular disease, right ventricular hypertrophy, and failure. In this article, the key determinants of this "dangerous liaison" are analyzed with some digressions on related "leitmotiv" at the horizon.
引用
收藏
页码:297 / +
页数:14
相关论文
共 50 条
  • [31] Creating interatrial shunts in heart failure and pulmonary hypertension
    Wolsk, Emil
    Gustafsson, Finn
    EUROINTERVENTION, 2016, 12 : X89 - X92
  • [32] Pulmonary Hypertension Associated with Left Heart Disease
    Adir, Yochai
    Amir, Offer
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (05) : 665 - 680
  • [33] Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
    Moles, Victor M.
    Grafton, Gillian
    CARDIOLOGY CLINICS, 2022, 40 (04) : 533 - 540
  • [34] Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial
    Garcia-Lunar, Ines
    Blanco, Isabel
    Fernandez-Friera, Leticia
    Prat-Gonzalez, Susanna
    Jorda, Paloma
    Sanchez, Javier
    Pereda, Daniel
    Pujadas, Sandra
    Rivas, Mercedes
    Sole-Gonzalez, Eduard
    Vazquez, Jorge
    Blazquez, Zorba
    Garcia-Picart, Juan
    Caravaca, Pedro
    Escalera, Noemi
    Garcia-Pavia, Pablo
    Delgado, Juan
    Segovia-Cubero, Javier
    Fuster, Valentin
    Roig, Eulalia
    Barbera, Joan Albert
    Ibanez, Borja
    Garcia-Alvarez, Ana
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2020, 5 (04): : 317 - 327
  • [35] Pulmonary hypertension due to left heart disease
    Berthelot, Emmanuelle
    Bailly, Minh Tam
    El Hatimi, Safwane
    Robard, Ingrid
    Rezgui, Hatem
    Bouchachi, Amir
    Montani, David
    Sitbon, Olivier
    Chemla, Denis
    Assayag, Patrick
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2017, 110 (6-7) : 420 - 431
  • [36] Pulmonary Hypertension Due to Left Heart Disease
    Al-Omary, Mohammed S.
    Sugito, Stuart
    Boyle, Andrew J.
    Sverdlov, Aaron L.
    Collins, Nicholas J.
    HYPERTENSION, 2020, 75 (06) : 1397 - 1408
  • [37] Pulmonary hypertension in advanced heart failure
    Ghio, S
    HERZ, 2005, 30 (04) : 311 - 317
  • [38] Right Heart Failure in Pulmonary Hypertension
    Cassady, Steven
    Ramani, Gautam, V
    CARDIOLOGY CLINICS, 2020, 38 (02) : 243 - +
  • [39] Hemodynamic Thresholds for Precapillary Pulmonary Hypertension
    Gerges, Christian
    Gerges, Mario
    Skoro-Sajer, Nika
    Zhou, Yi
    Zhang, Lixia
    Sadushi-Kolici, Roela
    Jakowitsch, Johannes
    Lang, Marie B.
    Lang, Irene M.
    CHEST, 2016, 149 (04) : 1061 - 1073
  • [40] Pathophysiology and potential treatments of pulmonary hypertension due to systolic left heart failure
    Lundgren, J.
    Radegran, G.
    ACTA PHYSIOLOGICA, 2014, 211 (02) : 314 - 333